Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

234,031-234,060 of 319,975

filter-aware
08
AstraZeneca | Results Presentation Deck | 38 slidesAstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
09
The chart uses color coding for different product categories, though no legend is provided.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
10
The slide includes a navigation bar at the top and a footer with footnotes and page number.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
11
Includes footnotes regarding rounding, CER (Constant Exchange Rate), and specific exclusions for Product Sales Gross Margin.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
12
Includes a waterfall chart for net debt and specific guidance updates for revenue and EPS.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
13
Features headshots of Dave Fredrickson and Susan Galbraith alongside a scientific illustration of antibodies.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
14
The slide uses a stacked bar chart to show revenue trends by product over time, paired with a list of qualitative drivers.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
15
The slide uses a two-column layout to separate solid tumor (bladder cancer) and haematology R&D updates.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Loop · Voice Of Customer1 hit
16
Slide 16 of a presentation deck. Includes a legend for established SoC vs ongoing trials.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Loop · Voice Of Customer1 hit
17
AstraZeneca | Results Presentation Deck | 38 slidesAstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Loop · Voice Of Customer1 hit
18
Slide 18 of a presentation. Includes revenue charts for CVRM and R&I segments and a list of key product growth drivers.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Loop · Voice Of Customer1 hit
19
The slide uses a matrix-like structure to map drug candidates against therapeutic areas and treatment strategies.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Loop · Voice Of Customer1 hit
20
The slide uses a split-layout: left side details the clinical trial results, right side lists pipeline expansion opportunities.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Loop · Voice Of Customer1 hit
21
AstraZeneca | Results Presentation Deck | 38 slidesAstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
22
Includes revenue breakdown by product (Ultomiris, Soliris, Strensiq, Others) over 8 quarters.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
23
The slide uses a split-panel layout to define the problem (NF1-PN) and the solution (KOMET trial results).AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
24
AstraZeneca | Results Presentation Deck | 38 slidesAstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
25
The slide uses a three-column layout to categorize growth drivers, with a footer highlighting the $80bn revenue goal.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
26
The slide uses a navigation bar at the top to indicate the current section is 'CEO Opening Remarks'.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
27
AstraZeneca | Results Presentation Deck | 38 slidesAstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
28
AstraZeneca | Results Presentation Deck | 38 slidesAstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
29
AstraZeneca | Results Presentation Deck | 38 slidesAstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
30
The slide uses a matrix structure to categorize clinical assets by disease stage and biomarker status (IO sensitive, EGFRm, etc.).AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
31
The slide uses a grid layout to categorize clinical trials (e.g., DESTINY-Breast, TROPION-Breast) against patient segments and treatment lines.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
32
Data presented in stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
33
Data presented in stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
34
Data presented in stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
35
Data presented in stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
36
Data presented in stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit
37
Data presented in stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 1 hit